Literature DB >> 4067318

Comparison of immunoblot and immunoprecipitation methods for analyzing cross-reactive antibodies to filarial antigens.

R Hussain, N A Kaushal, E A Ottesen.   

Abstract

Qualitative analysis of antibody responses in helminth infections is essential not only for developing better immunodiagnostic antigens but also for understanding immune recognition and its relevance to immunopathogenesis and protective immunity. In this study 2 qualitative analytic methods (immunoprecipitation and immunoblotting) were compared for the ability to define the extent of cross-reactivity in the serum antibodies from patients with various forms of filariasis (caused by Brugia malayi, Wuchereria bancrofti, Loa loa and Tetrapetalonema perstans) or other non filarial helminth infections (ascariasis, strongyloidiasis, trichinosis, echinococcosis and schistosomiasis). Our results demonstrated that the spectrum of cross-reactive antibodies identified by immunoprecipitation was limited because of the selective radiolabeling of particular filarial antigens, while immunoblotting was able to detect a much wider range of cross-reactive antibodies in both filarial and non-filarial serum pools. In addition, this latter procedure was easily adapted for simultaneous analysis of different antibody isotopes (e.g., IgE and IgG) to the same antigens in individual sera. Immunoblotting thus provides an excellent tool for studying the spectrum of antibodies of different isotypes evoked during helminth infections and for discriminating between those responses that are species-specific and those that are cross-reactive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067318     DOI: 10.1016/0022-1759(85)90436-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  1 in total

1.  T and B cell reactivity to adrenal antigens in autoimmune Addison's disease.

Authors:  M Freeman; A P Weetman
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.